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The Role of Ultrafiltration Therapy on Blood
Pressure of Hypertensive Chronic Hemodialysis
Children

Abstract: Hypervolemia is supposed to be
the principal factor in hypertension in chronic
hemodialysis adults. In this study, the role of
intensive ultrafiltration (UF) treatment to
reduce hypertension due to hypervolemia in
hemodialysis children was investigated. The
inferior vena cava (IVC) was also evaluated as
an index of UF therapy. Twenty-three
hemodialysis children with the mean age
10.6±3.1 years were classified due to their
blood pressure status. IVC measurements
were performed with 2-D echocardiography
and inferior vena cava index (IVCI) was
calculated as diameter of inferior vena cava
(mm)/ body surface area (m2 ). UF therapy
was applied to each hypervolemic patient for
four successive days and all of the patients
were followed up for 4 weeks. Plasma levels
of atrial natriuretic peptide (RIA),
noradrenalin (high performance liquid
chromotography) and plasma renin activity
(RIA) of three patients having persistent
hypertension were investigated. IVCI and
plasma atrial natriuretic peptide levels of 12

Introduction
Hypertension (HT) is very commonly associated with
chronic renal failure and blood pressure has a tendency to
increase as renal function is lost (1, 2, 3). HT in chronic
renal failure is supposed due to several factors as
activated circulating and local renin angiotensin system,
increased sympathetic activity, decreased sensitivity of the
baroreceptors and increased the loss of vasodepressors
produced by the kidneys such as PGEII, bradykinin and to
the abnormalities of renal medullolipin, L-argininederived agmatin, endothelin and nitric oxide (1, 3).
However, the most important factor in HT in chronic
renal failure is accepted as the volume overload (1, 3, 4,
5).
The fluid volume is assumed to be the principal factor
in determining hypertension in most adult patients with
chronic renal failure. Blood pressure can be corrected by

healthy children were studied as a control
group.
At the begining of the study, 11 patients had
hypertension and 14 patients had high IVCI.
14 hypervolemic children had UF therapy.
Eleven patients responded to UF therapy and
had normal blood pressures. After 4 weeks
of follow up period 12, patients were again
found to have hypertension. Following UF,
hypertension was persisted in 3 of them.
Since IVCI and ANP levels of these three
patients were high, hypervolemia or some
other factors was thought to be responsible
for hypertension. Volume overload was
found to be the most important factor in the
pathogenesis of HT in hemodialysis children.
UF was effective in reducing hypertension.
IVCI might be a reliable parameter to control
ultrafiltration therapy in the management of
hypervolemic hemodialysis children.
Key Words: Children; hemodialysis;
hypertension; hypervolemia; ultrafiltration.

removal of excess fluid and sodium through ultrafiltration
(UF), especially in uremic adults (4, 5). To our knowledge
the literature contains no controlled study pointing the
ratio of the volume factor in HT in dialysed children.
The aim of this study was to investigate the role of
intensive UF treatment to reduce hypertension due to
hypervolemia in children on chronic hemodialysis (HD)
and to evaluate inferior vena cava (IVC) as an index of UF
treatment.
Materials and Methods
Twenty-three patients, 10 girls and 13 boys, on
chronic hemodialysis program were admitted to the
study. Their ages ranged from 5 to 15 years with the
mean age 10.6±3.1 years. Eighteen of the patients had
HD 3 times a week and the remaining 5, twice a week
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Initial findings (pre-UF)
BLOOD
PRESSURE

SYSTOLIC
DIASTOLIC
mmHg
CLINICALLY
OVERLOAD
IVCI mm/m2

UF THERAPY (n)
Response to UF (n)

Findings after 4 weeks follow up period (post-UF)

≤90p
n:12

>90p
n:11

≤90p
n:11
Initial
hypertensive
n:8

Initial
normotensive
n:9

Initial
hypertensive
n:3

105.5±13.8
67.9±14.8

145.±20.7
94.1±15.3

93±58
63±15
(n:3)

114±11
75±8
(n:8)

152±16
98±19
(n:9)

163±25
93±12
(n:3)

0

11

0

0

9

3

8.2±1.2
9.5±0.7 n:3
7.7±1.2 n:9
3
3

10.4±1.0

8.6±0.4
n:8
0
0

9.7±2.0
n:9
9
9

11
8

8.9±2.0

Patients (n:3) with persisiting

Table 2.

The parameters investigated in
three patients having persistent
hypertension.

9.9±2.8
12.9±4.0
n:3
3
0

Normal values

hypertension after therapy
IVCI mm/m2

12.9±4.0

7.0±0.9 (12 healthy controls)

ANP pg/ml

143±25

102±39 (12 healthy controls)

PRA ng/ml/hr

0.8

0.8±0.4 (Normal range)

Noradrenalin (pg/ml)

128.1

104-548 (Normal range)

Adrenalin (pg/ml)

86.6

88 (Normal range)

with cuprophane dialysers. The dialysate was biarbonate
buffered and contained 133 mmol/l of sodium.
Clinical signs (dispne-ortopne, juguler venous
pulsation, hepatomegaly and gallop rhytym) and IVC
indices (IVCI) were investigated for detecting
overhydration in each patient. Hypertension was accepted
as the sistolic and diastolic blood pressure values over 90
percentile according to height and weight (6). Patients
were callisified into two groups due to their blood
pressure status as ≤90 percentile and >90 percentile. IVC
measurements were performed with 2-D color flow
doppler echocardiography (HP sonos 1000) by the same
cardiologist and IVCI was calculated as diameter of
IVC(mm) / body surface area (m2 ). IVC indices, found
higher than the values of the healthy control group, in
this study were accepted as overhydrated. We used 95%
confidence limits (mean±2 standard deviation) of the
control group to define overhydration in each patient
with or without hypertension. During the dialysis, UF
therapy was applied to each hypervolemic patient for four
successive days. For each patient the amount of
ultrafiltrated fluid was kept as 15% of the body weight.
All of the patients were followed up for 4 weeks. During
this period all of the patients were urged to restrict water
and salt intake. Plasma levels of atrial natriuretic peptide
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Evaluation of the patients
throughout the 4 weeks follow-up
period.

>90p
n:12

Initial
normotensive
n:3

7.5±1.0
n:3
0
0

Table 1.

(ANP), noradrenalin, adrenalin and plasma renin activity
(PRA) of the three patients having persistent HT were
also investigated. Radio immun assay (RIA) (AmershamANP Biodata renin MAIA KIT) was used to determine
plasma concentration of ANP and PRA. Noradrenalin and
adrenalin were investigated by high performance liquid
chromotgraphy with electrochemical detector. IVCI and
plasma ANP levels of 12 age equivalent healthy children
were studied as a control group.
Results
At the beginning of HD program, 11 of the 23
patients were found hypertensive. All of these
hypertensive children were also clinically fluid overloaded.
None of the other 12 normotensive patients showed any
signs of fluid overload. IVCI values were high in all 11
patients of hypertensive group. However 3 of 12
normotensive children presented a high IVCI without any
clinical signs of fluid overload. Thus, 14 of 23 patients
were accepted as fluid overloaded due to IVCI and were
commenced on UF treatment besides regular
hemodialysis. The mean ± SD values of IVCI were found
as 7.0±0.9 mm/m2 in healthy control group.
At the end of the 4 weeks follow-up period, it was
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observed that 11 patients had blood pressures below 90
percentilve while 12 patients had blood pressures above
90 percentile. When the patients were evaluated due to
their initial blood pressure values, it was found that nine
out of the 12 initially normotensive patients showed HT
during the follow-up period and the remaining 3 were
still normotensive. Although eight of the intially
hypertensive 11 patients, showed normal blood pressures
after the UF therapy, HT persisted in 3 of them. All of the
hypertensive patients in both groups were clinically
overloaded and showed high IVCI compared to the other
patients with normal blood pressure. Nine patients who
developed HT during the follow up period were treated
with UF and showed normal blood pressure
measurements after UF treatment. Only 3 patients from
the initially hypertensive group persisted to show high
blood pressure despite the UF treatment. The evaluation
of hemodialysis children at the beginning of the study and
at the end of follow-up period was given at table I. ANP,
PRA, adrenalin and noradrenalin values of the three
persisited hypertensive children were found in normal
ranges (Table 2).
Discussion
Hypervolemia and renin angiotensin system have been
accepted to be the most important two factors in the
pathophysiology of hypertension in chronic renal disease.
It was reported that at a glomerular filtration of 10 to
20% of normal, 95% of patients were hypertensive (3).
In this study, before and after the four weeks follow-up
period, 20 hypertensive patients (86.9 %) were totally
detected. As the renal function is impaired and
hemodialysis is necessary, the volume factor becomes
more important (1, 4, 5). Excess salt and water can only
be disposed by ultrafiltration (1). It was shown that 8085% of hypertensions in adult hemodialysis patients
could be controlled by UF therapy (1).
Initially 11 patients were found to have high blood
pressures while 9 patients had hypertension after the
following period. Although UF therapy was performed to
all of the patients having high blood pressures (n:20), 17
of them responded to the therapy. It was suggested that
HT of these patients who had normal blood pressures
following UF therapy was related to hypervolemia (Table
1). As a result 85% (n:17) of our pediatric hemodialysis
patients had hypertension due to volume factor as
mentioned in adults in the literature (1).
Echocardiography of IVC appairs to be available tool
in the assessment of postdialytic dry weight in adults (4,

7, 8, 9) and in children (10). In this study IVC index was
found to be correlated with HT, too. Initial hypertensive
group (n=11) were found to have high mean IVC indices
(10.1±1 mm/m2 ) at the beginning. Following the UF
therapy, 8 of these patients were found to have normal
blood pressures with lower IVC indices (8.6±0.4 mm/m2 )
and 3 with persistent hypertension had higher IVC indices
(12.9±4.0 mm/m2 ). However, 3 patients having initial
normal blood pressures also showed high mean IVC
indices (9.5±0.7 mm/m2 ). The same 3 patients had
normal blood pressures and IVC indices (7.5±10 mm/m2 )
after the following period. Since 21.4% of our overload
patients with high IVC indices did not show high blood
pressures, it was thought that IVCI was more valuable
tool in estimating the fluid status in hemodialysis children
than the clinical criteria including HT.
Inappropriate PRA, which may be caused by the
ectopic synthesis of renin, renal ischemia and activation of
the intrarenal baroreceptors, was found to be responsible
from HT in end stage renal failure (1, 2). During 4 weeks
of follow up, 3 patients (15%) had persistent HT. In
these patients who did not response to UF, PRA as a cause
of hypertension was investigated and was found normal.
None of the patients were supposed to have HT due to
excessive renin activity.
Role of sympathetic overactivity in end stage renal
failure was mentioned by some authors in the past and
with more solid evidence recently (1, 2). However,
persistent hypertensive patients did not show elevated
adrenalin and noradrenaline levels in this study.
Many studies have showed a correlation between ANP
and overhydration (5, 8, 10, 11). ANP concentrations of
3 patients having persistent HT were found higher
(143±25 p/ml) than normal (102±39). In addition these
3 patients had also high IVC indices as 12.9±4.0 mm/m2
at the end of UF therapy. All of these findings showed
that the remaining three patients might also have volume
overload despite the standard UF therapy. The standard
UF therapy might be inadequate to dispose excess salt and
water in these 3 patients. Other factors such as
abnormalities of renal medullopilin, L-arginine-derived
agmatin, endothelin or nitric oxide might also be
responsible for the hypertension.
In conclusion, hypervolemia was found to be the most
important factor in the pathogenesis of HT in
hemodialysis children. UF was observed to be effective in
reducing HT, and IVCI looks like a reliable parameter to
estimate hypervolemia and the response to ultrafiltration
therapy.
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